Company Overview:
Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements. Aleafia Health owns three major cannabis product & cultivation, two of which are licensed and operational. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators.
[stock_market_chart symbol=”ALEF.TO” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Key Share Information:
Current Share Price #N/A
Market Capitalization (in Millions) #N/A
Last Quarter 3/31/2019
Shares Outstanding (in Millions) 272.08
Options (in Millions) 17.81
Warrants (in Millions) 47.94
Fully Diluted (in Millions) 337.83
Enterprise Value (in Millions) #N/A
TTM Revenue $4.23
TTM Growth Margin % 324.09%
TTM Operating Expenses $11.06
TTM OCF -$4.20
P/S TTM #N/A
P/S (Last Quarter Run Rate) #N/A
Key Balance Sheet Information (in Millions $CAD):
CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ4'18 CYQ1'19
Cash 2.48 8.86 8.61 8.10 8.22 8.42 30.29 29.09 22.82 26.41 36.84
Biological Assets 0.91 0.23 0.75
Inventory 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.36 4.81
Total Assets 3.69 9.97 9.81 9.14 9.62 9.32 71.98 70.61 76.21 97.86 420.77
Net Tangible Assets 3.69 9.97 9.81 9.14 9.62 9.32 33.49 32.23 38.28 50.78 150.06
Intangibles/Goodwill 38.49 38.39 37.93 47.09 270.71
Total Liabilities 1.48 1.33 1.56 1.44 2.11 1.89 8.09 7.30 7.69 5.93 33.22
Key Operating Items (Quarterly in Millions $CAD):
CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ4'18 CYQ1'19
Revenue $2.08 $0.86 $0.89 $0.91 $3.87 $1.25 $0.12 $1.21 $1.64 3.33 1.52
Change in Fair Value of Biologial Assets 0.91 1.14 0.20
Gross Margin 1.30 2.79
Marketing and Sales $0.07
Investor Relations $0.12 $0.28 $0.23 $0.76 $0.08 $0.12 0.16 0.29 0.93 0.28
Total Operating Expenses $2.57 $4.04 $1.62 $1.38 $8.29 $1.33 $1.81 2.31 5.61 22.60 20.39
Operating Cash Flow (Quarterly) -$1.34 -$0.06 -$0.58 -$0.51 $0.11 -$0.22 -$2.05 -0.69 -1.23 -$6.53 $0.00
Investing Cash Flow (Quarterly) -$0.09 $0.07 -$0.03 -$0.01 $0.01 -$1.65 -$0.11 -0.57 -15.33 $6.80 $28.75
Financing Cash Flow (Quarterly) $3.79 $0.32 $0.36 $0.00 $0.00 $5.02 $31.20 0.06 10.30 $3.32 -$43.67
Listing Statement
